Journal article
Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8+ T-cell immunity
OncoImmunology, Vol.1(7), pp.1084-1094
2012
Abstract
An incomplete understanding on the effect of surgery on tumor-specific immunity continues to hamper efforts to combine surgery with immunotherapy in the clinic. Herein, we describe the impact of tumor resection on the tumor-specific T-cell response, showing that complete tumor resection is associated with (1) a decline in the amount of cross-presented tumor antigens, (2) a decline of cytolytic tumor-specific CD8+ T cell activity, and (3) the development of systemic CD8+ T cell-mediated protective immunity. Our findings are consistent with a model whereby tumor resection releases antitumor CD8+ T cells from chronic antigen exposure, allowing a gradual differentiation toward functional antitumor memory T cells. This process depends on sentinel lymph nodes, as their removal at the time of surgery was associated with a strong negative effect on survival. We conclude that complete tumor resection provides a unique environment that boosts protective immunological memory and might provide a powerful platform for immunotherapy. Our findings also carry important implications for the design and timing of post-surgery immunotherapeutic regimens.
Details
- Title
- Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8+ T-cell immunity
- Authors/Creators
- M.D. Brown (Author/Creator) - Sir Charles Gairdner HospitalR. van der Most (Author/Creator) - GSK Biologicals; Rixensart, BelgiumJ.B. Vivian (Author/Creator) - The University of Western AustraliaR.A. Lake (Author/Creator) - The University of Western AustraliaI. Larma (Author/Creator) - Sir Charles Gairdner HospitalB.W.S. Robinson (Author/Creator) - The University of Western AustraliaA.J. Currie (Author/Creator) - National Research Centre for Asbestos Related Diseases; University of Western Australia; Perth, Australia; School of Veterinary and Biomedical Sciences; Murdoch University; Perth, Australia
- Publication Details
- OncoImmunology, Vol.1(7), pp.1084-1094
- Publisher
- Landes Bioscience
- Identifiers
- 991005544680907891
- Copyright
- © 2012 Landes Bioscience
- Murdoch Affiliation
- School of Veterinary and Biomedical Sciences
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
811 File views/ downloads
50 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.6 Immunology
- 1.6.358 Dendritic Cell Therapy
- Web Of Science research areas
- Immunology
- Oncology
- ESI research areas
- Biology & Biochemistry